Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma
NCT01880632
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Gastric Adenocarcinoma
Interventions
DRUG:
XELOX
Sponsor
Shanghai Zhongshan Hospital
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]